Authors:
van Elden, LJR
van Essen, GA
Boucher, CAB
van Loon, AM
Nijhuis, M
Schipper, P
Verheij, TJM
Hoepelman, IM
Citation: Ljr. Van Elden et al., Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice, BR J GEN PR, 51(469), 2001, pp. 630-634
Authors:
van Elden, LJR
Nijhuis, M
Schipper, P
Schuurman, R
van Loon, AM
Citation: Ljr. Van Elden et al., Simultaneous detection of influenza viruses A and B using real-time quantitative PCR, J CLIN MICR, 39(1), 2001, pp. 196-200
Authors:
Back, NKT
van Wijk, A
Remmerswaal, D
van Monfort, M
Nijhuis, M
Schuurman, R
Boucher, CAB
Citation: Nkt. Back et al., In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors, AIDS, 14(1), 2000, pp. 101-102
Authors:
Frost, SDW
Nijhuis, M
Schuurman, R
Boucher, CAB
Brown, AJL
Citation: Sdw. Frost et al., Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection, J VIROLOGY, 74(14), 2000, pp. 6262-6268
Authors:
Sevin, AD
DeGruttola, V
Nijhuis, M
Schapiro, JM
Foulkes, AS
Para, MF
Boucher, CAB
Citation: Ad. Sevin et al., Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS Clinical Trials Group 333, J INFEC DIS, 182(1), 2000, pp. 59-67
Authors:
Nijhuis, M
Schuurman, R
de Jong, D
Erickson, J
Gustchina, E
Albert, J
Schipper, P
Gulnik, S
Boucher, CAB
Citation: M. Nijhuis et al., Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy, AIDS, 13(17), 1999, pp. 2349-2359